Patricia L. Rubio

Hospital De Pediatría Prof. Dr. Juan P. Garrahan
B, Argentina

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Retinoblastoma in Argentina: study of germline variants of the RB1 gene

Retinoblastoma in Argentina: study of germline variants of the RB1 gene

Journal: Medicina

Published: February 05, 2026

Immune Response and Safety of Anti-NeuGcGM3 Anti-Idiotype Vaccine Racotumomab in Patients With High-Risk Neuroblastoma: An Open-Label, Single-Arm, Multicenter Phase 2 Study in Argentina.

Immune Response and Safety of Anti-NeuGcGM3 Anti-Idiotype Vaccine Racotumomab in Patients With High-Risk Neuroblastoma: An Open-Label, Single-Arm, Multicenter Phase 2 Study in Argentina.

Journal: Pediatric blood & cancer

Published: December 23, 2025

Clinical presentation of non-malignant diseases mimicking leukemia cutis: A report of two cases.

Clinical presentation of non-malignant diseases mimicking leukemia cutis: A report of two cases.

Journal: Archivos argentinos de pediatria

Published: March 01, 2023

Impact of IKZF1 Deletions in the Prognosis of Childhood Acute Lymphoblastic Leukemia in Argentina.

Impact of IKZF1 Deletions in the Prognosis of Childhood Acute Lymphoblastic Leukemia in Argentina.

Journal: Cancers

Published: September 20, 2021

Clonal Myeloproliferative Disorders in Patients with Down Syndrome-Treatment and Outcome Results from an Institution in Argentina.

Clonal Myeloproliferative Disorders in Patients with Down Syndrome-Treatment and Outcome Results from an Institution in Argentina.

Journal: Cancers

Published: September 02, 2021

Measurable residual disease by rearrangements of immunoglobulins and T-lymphocyte receptors

Measurable residual disease by rearrangements of immunoglobulins and T-lymphocyte receptors

Journal: Medicina

Published: June 17, 2021

No benefit of Interfant protocols compared to BFM-based protocols for infants with acute lymphoblastic leukemia. Results from an institution in Argentina.

No benefit of Interfant protocols compared to BFM-based protocols for infants with acute lymphoblastic leukemia. Results from an institution in Argentina.

Journal: Pediatric blood & cancer

Published: December 30, 2019

Validation of the United Kingdom copy-number alteration classifier in 3239 children with B-cell precursor ALL.

Validation of the United Kingdom copy-number alteration classifier in 3239 children with B-cell precursor ALL.

Journal: Blood advances

Published: September 05, 2018

Cytoplasmic CD3 expression in infant acute megakaryoblastic leukemia: A new ambiguous lineage subtype?

Cytoplasmic CD3 expression in infant acute megakaryoblastic leukemia: A new ambiguous lineage subtype?

Journal: Leukemia research

Published: March 21, 2018

Second Neoplasms in Children Following a Treatment for Acute Leukemia and/or Lymphoma: 29 Years of Experience in a Single Institution in Argentina.

Second Neoplasms in Children Following a Treatment for Acute Leukemia and/or Lymphoma: 29 Years of Experience in a Single Institution in Argentina.

Journal: Journal of pediatric hematology/oncology

Published: September 26, 2017

Mycosis Fungoides: Experience in a Pediatric Hospital.

Mycosis Fungoides: Experience in a Pediatric Hospital.

Journal: Actas dermo-sifiliograficas

Published: May 06, 2016

B-cell acute lymphoblastic leukemia with mature phenotype and MLL rearrangement: report of five new cases and review of the literature.

B-cell acute lymphoblastic leukemia with mature phenotype and MLL rearrangement: report of five new cases and review of the literature.

Journal: Leukemia & lymphoma

Published: February 10, 2016

Showing 1-12 of 17

Last Updated: 09/26/2026